SCHEMBL722030

SCHEMBL722030

COCC1COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22582696 0.89
SCHEMBL11569910 0.82
SCHEMBL18759001 0.81
SCHEMBL15491974 0.79
SCHEMBL1145946 0.79
SCHEMBL2513311 0.76
SCHEMBL21430659 0.76
SCHEMBL12015522 0.76
SCHEMBL5548048 0.75 TSHR (0.32)
SCHEMBL9211070 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609097-A1 PYRIDYL-AMINE FUSED AZADECALIN MODULATORS Corcept Therapeutics, Inc. (US) 2013-07-03 EP claimed
WO-2012027702-A1 PYRIDYL-AMINE FUSED AZADECALIN MODULATORS CORCEPT THERAPEUTICS, INC. (US) 2012-03-01 WO claimed
EP-3856736-B1 NOVEL COMPOUNDS AS NADPH OXIDASE INHIBITORS CALLIDITAS THERAPEUTICS SUISSE SA (CH) 2026-05-06 EP disclosed
US-12202816-B2 Compounds as NADPH oxidase inhibitors CALLIDITAS THERAPEUTICS SUISSE SA (CH) 2025-01-21 US disclosed
US-20240270740-A1 INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. 2024-08-15 US disclosed
CN-117903110-A HBV inhibitors and uses thereof 西安新通药物研究股份有限公司 2024-04-19 CN disclosed
US-11912708-B2 Macrocyclic heterocycles and uses thereof KUMQUAT BIOSCIENCES INC. (US) 2024-02-27 US disclosed
CN-114901639-B HBV inhibitors and uses thereof 西安新通药物研究股份有限公司 2023-11-24 CN disclosed
US-20230165251-A1 SUBSTITUTED TOLYL FUNGICIDES AND THEIR MIXTURES FMC CORPORATION 2023-06-01 US disclosed
US-20230029385-A1 2-METHYL-AZA-QUINAZOLINES BAYER AG (DE) 2023-01-26 US disclosed
CN-114901639-A HBV inhibitor and application thereof 西安新通药物研究股份有限公司 2022-08-12 CN disclosed
US-8426111-B2 Resist underlayer coating forming composition for forming photo-crosslinking cured resist underlayer coating NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-04-23 US disclosed
US-20120220565-A1 PYRIDYL-AMINE FUSED AZADECALIN MODULATORS CORCEPT THERAPEUTICS, INC. (US) 2012-08-30 US disclosed
CN-102482473-A Photocurable fluoropolymer composition ASAHI GLASS CO LTD 2012-05-30 CN disclosed
WO-2012027702-A1 PYRIDYL-AMINE FUSED AZADECALIN MODULATORS CORCEPT THERAPEUTICS, INC. (US) 2012-03-01 WO disclosed
EP-1745083-B1 HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION BLUESTAR SILICONES FRANCE (FR) 2009-12-16 EP disclosed
US-20090130594-A1 Resist Underlayer Coating Forming Composition for Forming Photo-Crosslinking Cured Resist Underlayer Coating NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-05-21 US disclosed
EP-1428823-B1 LIQUID-CRYSTALLINE OXETANE COMPOUND, POLYMERIZABLE LIQUID-CRYSTALLINE COMPOSITION, PROCESS FOR PRODUCING LIQUID-CRYSTAL FILM, OPTICAL FILM, AND LIQUID-CRYSTAL DISPLAY NIPPON OIL CORP (JP) 2007-07-11 EP disclosed
US-4047963-A ETHYLENE OXIDE COPOLYMER, UNSATURATED MONOMER, PHOTOINITIATOR HERCULES INCORPORATED (US) 1977-09-13 US disclosed
US-4009128-A Polymerization of epoxides HERCULES INCORPORATED (US) 1977-02-22 US disclosed